PT89057A - Expressao de proteina de hiv em e. coli e s. cerevisiae - Google Patents

Expressao de proteina de hiv em e. coli e s. cerevisiae

Info

Publication number
PT89057A
PT89057A PT89057A PT8905788A PT89057A PT 89057 A PT89057 A PT 89057A PT 89057 A PT89057 A PT 89057A PT 8905788 A PT8905788 A PT 8905788A PT 89057 A PT89057 A PT 89057A
Authority
PT
Portugal
Prior art keywords
cerevisiae
coli
expression
hiv protein
hiv
Prior art date
Application number
PT89057A
Other languages
English (en)
Inventor
Teresa Cabezon
Michel De Wilde
Apolonia Rutgers
Original Assignee
Smithkline Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Biolog filed Critical Smithkline Biolog
Publication of PT89057A publication Critical patent/PT89057A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
PT89057A 1987-11-24 1988-11-23 Expressao de proteina de hiv em e. coli e s. cerevisiae PT89057A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12419887A 1987-11-24 1987-11-24

Publications (1)

Publication Number Publication Date
PT89057A true PT89057A (pt) 1989-11-30

Family

ID=22413400

Family Applications (1)

Application Number Title Priority Date Filing Date
PT89057A PT89057A (pt) 1987-11-24 1988-11-23 Expressao de proteina de hiv em e. coli e s. cerevisiae

Country Status (6)

Country Link
EP (1) EP0322394A3 (pt)
JP (1) JPH022361A (pt)
AU (1) AU2579688A (pt)
DK (1) DK643188A (pt)
PT (1) PT89057A (pt)
ZA (1) ZA888701B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130247A (en) * 1989-09-19 1992-07-14 Merck & Co., Inc. Expression of fusion protein of HIV envelope and HBsAG
US5130248A (en) * 1989-09-19 1992-07-14 Merck & Co., Inc. Expression of fusion protein of HIV envelope and HBsAg
NZ235538A (en) * 1989-10-12 1992-06-25 Viral Technologies Inc Peptides immunoreactive with antibodies to hiv p17; carrier-bound peptides, vaccines, immunoassay and a method for forming antibody enriched sera
JP3853384B2 (ja) * 1994-09-09 2006-12-06 株式会社三菱化学ヤトロン 抗サイモシンα１モノクローナル抗体産生ハイブリドーマ
ITTO20020286A1 (it) * 2002-03-29 2003-09-29 Medestea Int Spa Uso della proteina p17 isolata per la preparazione di un medicamento atto ad inibire gli effetti immunostimolanti che la proteina prodotta d
GB0417494D0 (en) * 2004-08-05 2004-09-08 Glaxosmithkline Biolog Sa Vaccine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341423C (en) * 1984-10-31 2003-03-04 Paul A. Luciw Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
ES8706824A1 (es) * 1985-04-08 1987-07-01 Genetic Systems Corp Un metodo para preparar proteinas que son inmunologicamente reactivas con anticuerpos para virus asociados con linfadenopatia.
AU6713287A (en) * 1986-01-06 1987-07-09 F. Hoffmann-La Roche & Co. Expression of htlv-iii gag-gene
EP0293792A3 (en) * 1987-06-01 1990-01-17 The Du Pont Merck Pharmaceutical Company Human immunodeficiency virus gag-encoded proteins

Also Published As

Publication number Publication date
AU2579688A (en) 1989-05-25
EP0322394A3 (en) 1990-05-09
DK643188D0 (da) 1988-11-17
DK643188A (da) 1989-05-25
ZA888701B (en) 1990-08-29
EP0322394A2 (en) 1989-06-28
JPH022361A (ja) 1990-01-08

Similar Documents

Publication Publication Date Title
ATE91025T1 (de) Bestimmung von kaliumionen in fluessigkeiten.
NL960006I1 (nl) Purine-derivaten en de farmaceutische toepassing daarvan.
IL91843A0 (en) Hiv proteins and peptides useful in the diagnosis,prophylaxis aids or therapy of aids
DK203187D0 (da) Human g-csf proteinekspression
DK299087D0 (da) Proteins and derivatives thereof
DK0455396T3 (da) Vandige gelpræparater og deres anvendelse.
NO882226L (no) Fibrinolytiske proteiner.
DE3885105D1 (de) Kombinierte ruder- und schraubenanordnung.
ES2018608B3 (es) Perfeccionamientos en y relacionados con espejos moviles.
FI883940A7 (fi) Uusia HIV-proteiineja, jotka ovat käyttökelpoisia diagnostisoitaessa, ennakolta ehkäistäessä ja hoidettaessa AIDS-sairautta
DK639988D0 (da) Peptider samt anvendelse deraf.
NO890774D0 (no) Ekspresjon av hiv-bindende proteiner.
FI884991L (fi) Foerfarande foer reglering av protein glykolysation.
PT89057A (pt) Expressao de proteina de hiv em e. coli e s. cerevisiae
NO895031D0 (no) 2-imino-6-polyfluoralkoksybenzotiazol samt fremstilling derav.
DK109590D0 (da) Biologisk aktivt protein
DK355888A (da) Peptid samt anvendelsen heraf
NO891844L (no) Fibronektinbindende protein samt fremstilling derav.
FI863159A7 (fi) Sydänlääkkeinä käytettäviä heterosyklokarbonyyli- ja asetyylitiatsoloneja.
FI885025A7 (fi) Hyytymistä estävä proteiini PP4-X, sen valmistus ja käyttö
DE69012958D1 (de) Fibrinolytisches Protein und Herstellungsweise dafür.
DE59105421D1 (de) Mikrobiologische Oxidation von Ethylgruppen in Heterocyclen.
NO891715D0 (no) Ekspresjon av interferon-8 i metylotrofe gjaersorter.
NO912099L (no) Ekspresjon av hiv-proteiner i drosophilia-celler.
FR2600648B1 (fr) N-imidazolylmethyl-diphenylazomethines, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
FC3A Refusal

Effective date: 19940316